First Turn Management, LLC
CIK 1993440 · Lihat di SEC EDGAR ↗
- Nilai Portofolio
- $934.7M
- Posisi
- 31
- Per tanggal
- 30 Juni 2026
#2.559 dari 9.443 berdasarkan nilai 13F · top 27.1%
Nilai portofolio QoQ: +4.4% 13F tidak mengungkapkan kas
- Bobot 10 kepemilikan teratas
- 53,58%
- Bobot 25 kepemilikan teratas
- 93,03%
- Posisi di atas 1%
- 29
- Jumlah posisi efektif
- 23,8
Berdasarkan kepemilikan ekuitas jangka panjang 13F saja (kas, obligasi, posisi jual tidak diungkapkan)
Perputaran Q2 2026: 23,58% Perkiraan pembelian $215.747.621 · penjualan $322.552.612
Kepemilikan median: 3,0 kuartal Dilacak Q4 2024–Q2 2026 · 41,9% masih dipegang
- Posisi baru
- 6
- Meningkat
- 13
- Menurun
- 11
- Tertutup
- 8
Di halaman ini
- Kinerja vs S&P Bagaimana portofolio 13F manajer ini berkinerja terhadap S&P 500.
- Rincian sektor Bagaimana portofolio terbagi di berbagai sektor pasar.
- Portofolio Setiap saham yang dilaporkan dimiliki oleh institusi ini, dari 13F terbarunya.
- Taruhan Bernilai Tinggi Kepemilikan yang paling terkonsentrasi pada manajer ini.
- Taruhan baru terbesar Posisi baru yang dibuka pada kuartal terakhir.
- Pergerakan Teratas Peningkatan dan penurunan posisi terbesar pada kuartal ini.
- Posisi yang keluar Posisi yang sepenuhnya dijual oleh manajer pada kuartal lalu.
Kinerja vs S&P 500
Tahunan: +40.5% · S&P 500: +18.0%
Perkiraan portofolio beli-dan-tahan yang dibangun dari snapshot 13F SEC triwulanan. Mengecualikan kas, posisi jual, opsi/derivatif, dan sekuritas non-13(f) — mencerminkan buku ekuitas long yang diungkapkan saja, bukan total AUM dana. Keterlambatan pengajuan SEC hingga 45 hari; ini bukan waktu yang dapat disalin secara real-time.
Cakupan yang dapat dihargai: 97,8% · Opsi dikecualikan: 0,0%
Rincian sektor
Healthcare
97,0%
Lainnya/Tidak terpetakan
3,0%
Portofolio lengkap 31 posisi
| Tipe | Rentetan | Tren 8 kuartal | |||||
|---|---|---|---|---|---|---|---|
| RVMD Revolution Medicines, Inc. - Common Stock | $77.778.695 | 8,32% | 415.307 | $32.229.129 | Turun ×3 | ||
| ABVX Abivax SA - American Depositary Shares | $65.282.608 | 6,98% | 489.889 | $13.408.095 | Naik ×3 | ||
| AXSM Axsome Therapeutics, Inc. - Common Stock | $53.461.440 | 5,72% | 218.415 | $21.555.197 | Naik ×1 | ||
| ELVN Enliven Therapeutics, Inc. - Common Stock | $48.433.770 | 5,18% | 954.360 | $23.979.281 | Naik ×1 | ||
| BBIO BridgeBio Pharma, Inc. - Common Stock | $47.172.951 | 5,05% | 633.364 | $-4.491.068 | Turun ×1 | ||
| ROIV Roivant Sciences Ltd. - Common Shares | $47.106.426 | 5,04% | 1.331.066 | $14.140.157 | Naik ×3 | ||
| UTHR United Therapeutics Corporation - Common Stock | $46.018.706 | 4,92% | 84.932 | $-16.081.717 | Turun ×1 | ||
| CYTK Cytokinetics, Incorporated - Common Stock | $44.930.228 | 4,81% | 527.412 | $26.231.561 | Naik ×1 | ||
| XENE Xenon Pharmaceuticals Inc. - Common Shares | $36.228.072 | 3,88% | 600.200 | $-9.526.907 | Turun ×2 | ||
| CELC Celcuity Inc. - Common Stock | $34.430.547 | 3,68% | 329.101 | $10.395.174 | Naik ×1 | ||
| VRDN Viridian Therapeutics, Inc. - Common Stock | $30.677.900 | 3,28% | 1.670.000 | $12.852.148 | Naik ×2 | ||
| INSM Insmed Incorporated - Common Stock | $28.131.794 | 3,01% | 263.851 | $-12.498.838 | Naik ×1 | ||
| QURE uniQure N.V. - Ordinary Shares | $28.047.086 | 3,00% | 608.925 | $17.983.841 | Turun ×1 | ||
| Penerbit tidak dikenal (CUSIP: K08588103) | $27.972.793 | 2,99% | 104.877 | Naik ×1 | |||
| PRAX Praxis Precision Medicines, Inc. - Common Stock | $27.964.339 | 2,99% | 83.528 | $14.290.273 | Naik ×2 | ||
| DNTH Dianthus Therapeutics, Inc. - Common Stock | $27.856.957 | 2,98% | 285.771 | $9.317.267 | Naik ×1 | ||
| PCVX Vaxcyte, Inc. - Common Stock | $25.800.187 | 2,76% | 443.836 | ||||
| MIRM Mirum Pharmaceuticals, Inc. - common stock | $25.527.231 | 2,73% | 218.051 | $-11.467.633 | Turun ×3 | ||
| PVLA Palvella Therapeutics, Inc. - Common Stock | $23.908.689 | 2,56% | 156.450 | $5.448.897 | Naik ×1 | ||
| COGT Cogent Biosciences, Inc. - Common Stock | $23.308.275 | 2,49% | 602.281 | $-13.154.803 | Turun ×1 | ||
| ERAS Erasca, Inc. - Common Stock | $22.381.929 | 2,39% | 1.221.721 | $8.343.530 | Naik ×1 | ||
| ORIC Oric Pharmaceuticals, Inc. - Common Stock | $21.847.186 | 2,34% | 2.017.284 | $-3.711.802 | |||
| NAMS NewAmsterdam Pharma Company N.V. - Ordinary Shares | $19.740.823 | 2,11% | 582.497 | $1.868.488 | Naik ×1 | ||
| APGE Apogee Therapeutics, Inc. - Common Stock | $18.425.844 | 1,97% | 138.822 | $-24.818.177 | Turun ×1 | ||
| RYTM Rhythm Pharmaceuticals, Inc. - Common Stock | $17.100.619 | 1,83% | 154.018 | ||||
| INBX Inhibrx Biosciences, Inc. - Common Stock | $15.613.189 | 1,67% | 164.783 | Naik ×1 | |||
| SRRK Scholar Rock Holding Corporation - Common Stock | $14.917.485 | 1,60% | 271.227 | $-7.027.047 | Turun ×2 | ||
| ORKA Oruka Therapeutics, Inc. - Common Stock | $14.783.993 | 1,58% | 155.343 | Naik ×1 | |||
| KYMR Kymera Therapeutics, Inc. - Common Stock | $11.757.459 | 1,26% | 102.533 | $-9.454.172 | Turun ×1 | ||
| SION Sionna Therapeutics, Inc. - Common Stock | $4.860.587 | 0,52% | 110.493 | Naik ×1 | |||
| NUVL Nuvalent, Inc. - Class A Common Stock | $3.247.803 | 0,35% | 26.298 | $-34.693.940 | Turun ×1 | ||
| Tidak ada hasil | |||||||
Kepemilikan dengan keyakinan
Posisi meningkat selama 3+ kuartal berturut-turut.
Jumlah saham dilaporkan dalam pengajuan 13F (tidak disesuaikan split)
Taruhan baru terbesar
Posisi baru dibuka kuartal ini, terbesar diurutkan pertama.
Penggerak teratas (QoQ)
| Sekuritas | Aksi | Saham Δ | Nilai Δ |
|---|---|---|---|
| RVMD | Dipangkas | -53K | +$32.2M |
| CYTK | Beli lebih banyak | +244K | +$26.2M |
| APGE | Dipangkas | -375K | -$24.8M |
| ELVN | Beli lebih banyak | +331K | +$24.0M |
| AXSM | Beli lebih banyak | +30K | +$21.6M |
| QURE | Dipangkas | -7K | +$18.0M |
| UTHR | Dipangkas | -20K | -$16.1M |
| PRAX | Beli lebih banyak | +41K | +$14.3M |
| ROIV | Beli lebih banyak | +141K | +$14.1M |
| ABVX | Beli lebih banyak | +24K | +$13.4M |
1 posisi disembunyikan (pemeriksaan kelengkapan data)
Posisi yang keluar
Termasuk peristiwa perusahaan (merger, delisting) — tidak semua keluar adalah penjualan
Posisi tertutup mencerminkan perubahan pelaporan 13F; bagi manajer indeks, ini sering kali mekanis (penghapusan pencatatan, M&A, penyeimbangan ulang indeks), bukan keputusan aktif.
| Sekuritas | Kuartal | Saham sebelumnya | Nilai sebelumnya | Harga sejak keluar |
|---|---|---|---|---|
| MRUS | 31 Des. 2025 | 372.022 | $35.025.871 | Tidak lagi dilacak |
| VRNA | 30 Sep. 2025 | 309.988 | $29.318.665 | Tidak lagi dilacak |
| IDYA | 30 Juni 2026 | 873.838 | $29.116.282 | 4,3% |
| GH | 31 Maret 2026 | 271.685 | $27.749.906 | 74,3% |
| ACLX | 31 Des. 2025 | 313.733 | $25.757.479 | Tidak lagi dilacak |
| NBIX | 31 Des. 2025 | 181.897 | $25.534.701 | 9,6% |
| ITCI | 31 Maret 2025 | 294.414 | $24.589.457 | Tidak lagi dilacak |
| CRNX | 31 Maret 2025 | 453.376 | $23.181.115 | 152,7% |
| ARGX | 31 Maret 2026 | 23.256 | $19.557.133 | 39,6% |
| AKRO | 31 Des. 2025 | 397.010 | $18.850.035 | Tidak lagi dilacak |
| ISRG | 30 Sep. 2025 | 32.305 | $17.554.860 | -10,0% |
| ASND | 30 Juni 2026 | 76.300 | $17.452.099 | -4,0% |
| FULC | 30 Juni 2026 | 2.256.109 | $17.304.356 | 7,2% |
| TERN | 30 Juni 2026 | 326.694 | $17.223.308 | Tidak lagi dilacak |
| VERA | 30 Juni 2026 | 422.023 | $16.977.985 | -23,1% |
| NTRA | 30 Juni 2026 | 81.077 | $16.214.589 | 16,1% |
| PODD | 30 Sep. 2025 | 51.408 | $16.151.365 | -50,7% |
| TGTX | 30 Sep. 2025 | 447.884 | $16.119.345 | 41,4% |
| ELVN | 31 Des. 2025 | 783.411 | $16.036.423 | 282,9% |
| GH | 30 Sep. 2025 | 302.307 | $15.732.056 | 157,7% |
| RYTM | 31 Maret 2026 | 146.303 | $15.660.273 | 35,1% |
| JANX | 31 Des. 2025 | 639.699 | $15.634.244 | 25,4% |
| BSX | 30 Sep. 2025 | 138.834 | $14.912.160 | -47,1% |
| GERN | 31 Maret 2025 | 3.893.327 | $13.782.378 | -0,9% |
| RCUS | 31 Maret 2026 | 565.142 | $13.467.334 | 43,0% |
| SWTX | 30 Juni 2025 | 304.076 | $13.418.874 | Tidak lagi dilacak |
| GKOS | 30 Juni 2025 | 136.241 | $13.408.839 | 81,4% |
| EXAS | 30 Juni 2025 | 300.909 | $13.026.351 | Tidak lagi dilacak |
| IRON | 31 Maret 2026 | 153.206 | $12.166.088 | 26,5% |
| DAWN | 31 Maret 2025 | 947.878 | $12.009.614 | Tidak lagi dilacak |
| ADMA | 31 Des. 2025 | 808.673 | $11.855.146 | -45,4% |
| ACLX | 31 Maret 2025 | 152.356 | $11.684.182 | Tidak lagi dilacak |
| OLMA | 30 Juni 2026 | 768.662 | $11.460.750 | -11,3% |
| RDNT | 30 Sep. 2025 | 197.759 | $11.254.465 | -1,3% |
| PCVX | 30 Juni 2025 | 276.905 | $10.455.933 | 91,4% |
| BHVN | 31 Maret 2025 | 262.442 | $9.802.209 | -40,2% |
| HQY | 30 Sep. 2025 | 80.880 | $8.472.989 | 9,3% |
| CRMD | 31 Maret 2025 | 1.021.421 | $8.273.510 | 33,9% |
| BPMC | 30 Juni 2025 | 92.033 | $8.145.841 | Tidak lagi dilacak |
| SPRY | 30 Sep. 2025 | 455.953 | $7.956.380 | -34,9% |
| HROW | 31 Des. 2025 | 160.234 | $7.720.074 | -15,0% |
| SLNO | 30 Sep. 2025 | 86.332 | $7.232.895 | Tidak lagi dilacak |
| MLTX | 30 Juni 2025 | 179.196 | $7.001.188 | -65,2% |
| BCAX | 31 Maret 2025 | 346.170 | $6.030.281 | 100,8% |
| MLTX | 30 Juni 2026 | 315.563 | $5.882.094 | -15,6% |
| SNDX | 31 Maret 2025 | 441.587 | $5.837.780 | 67,2% |
| ALNY | 30 Sep. 2025 | 17.879 | $5.830.163 | -47,3% |
| PRAX | 30 Juni 2025 | 71.775 | $2.718.119 | 778,4% |
| KALV | 30 Sep. 2025 | 214.138 | $2.420.830 | Tidak lagi dilacak |
| BBNX | 30 Sep. 2025 | 157.194 | $2.288.745 | 2,4% |